Abstract
Mammographic screening is effective in reducing mortality from breast cancer. The issue is not whether mammography is effective, but whether the false positive rate and false negative rates can be reduced. This review will discuss controversies including the reduction in breast cancer mortality, overdiagnosis, the ideal screening candidate, and the optimal imaging modality for breast cancer screening. The article will compare and contrast screening mammography, tomosynthesis, whole-breast screening ultrasound, magnetic resonance imaging, and molecular breast imaging. Though supplemental imaging modalities are being utilized to improve breast cancer diagnosis, mammography still remains the gold standard for breast cancer screening.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 279-282 |
| Number of pages | 4 |
| Journal | Clinical Imaging |
| Volume | 40 |
| Issue number | 2 |
| DOIs | |
| State | Published - Mar 1 2016 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'Breast cancer screening controversies: Who, when, why, and how?'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver